Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dexamethasone suppression test and suicide attempts.

A Schmidtke1, P Fleckenstein, H Beckmann

  • 1Department of Psychiatry, University of Würzburg, Federal Republic of Germany.

Acta Psychiatrica Scandinavica
|March 1, 1989
PubMed
Summary

The dexamethasone suppression test (DST) did not significantly correlate with suicidal behavior in patients, even when controlling for suicide attempt methods and diagnoses. This finding challenges previous hypotheses linking DST results to suicide risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

BAY 81-8973, a full-length recombinant factor VIII: results from an International comparative laboratory field study.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Reasons for Attempted Suicide in Europe: Prevalence, Associated Factors, and Risk of Repetition.

Archives of suicide research : official journal of the International Academy for Suicide Research·2016
Same author

[Suicidal behavior: a psychiatric emergency situation, suicide prevention: a psychiatric obligation].

Der Nervenarzt·2015

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • The dexamethasone suppression test (DST) is a biomarker historically investigated for its association with suicidal behavior.
  • Previous hypotheses suggested a link between DST non-suppression and increased suicide risk, particularly in depressed patients.
  • Understanding neuroendocrine correlates of suicidal behavior is crucial for improving risk assessment and treatment strategies.

Purpose of the Study:

  • To investigate the covariation between dexamethasone suppression test (DST) results and suicidal behavior in patients with a history of suicide attempts.
  • To control for confounding factors such as suicide methods, psychiatric diagnoses, and time factors in the analysis.
  • To compare DST results in patients with suicide attempts against control groups of psychiatric patients and those with endogenous depression.

Related Experiment Videos

Main Methods:

  • Examined DST results in 44 patients with at least one prior suicide attempt.
  • Controlled for suicide methods, diagnoses, and time factors.
  • Utilized control groups: 82 psychiatric patients and 69 patients with endogenous depression.
  • Performed chi-square tests using ICD-9 suicide classifications and subcategories.
  • Assessed Hamilton Rating Scale for Depression profiles for DST suppressors and non-suppressors.

Main Results:

  • No significant relationship was found between DST results and acute suicide attempts.
  • Patients using 'soft' suicide methods were often DST suppressors, but this covariation was not statistically significant.
  • The sensitivity of the DST for suicide attempts in patients with endogenous depression was 52%.
  • No significant differences were observed in the history of suicide attempts between DST suppressors and non-suppressors.
  • Hamilton Rating Scale for Depression profiles showed no significant differences in symptoms or acute suicide risk between DST suppressors and non-suppressors.

Conclusions:

  • The dexamethasone suppression test (DST) does not appear to be a reliable predictor of suicidal behavior, even in patients with a history of attempts.
  • The study failed to establish a significant covariation between DST results and suicide attempts, irrespective of method or diagnosis.
  • Further research may be needed to explore other biological or psychological markers for assessing suicide risk.